文献速递泌尿生殖腹部MR

表观扩散系数可区分T1高信号小肾肿块中的恶性病变

Apparent Diffusion Coefficient Distinguishes Malignancy in T1-Hyperintense Small Renal Masses.
PubMed 文献 · AJR Am J Roentgenol · 2019-10-01

本单中心回顾性研究纳入95例患者的58个良性及37个恶性T1高信号小肾肿块(<4 cm),由两名腹部放射科医师独立测量病灶ADC并归一化为ADCratio。恶性组ADCratio显著低于良性组(0.65±0.29 vs 1.03±0.32,p<0.001),控制病灶大小后ADCratio仍为恶性显著预测因子(p<0.001)。

要点

  • T1高信号小肾肿块中,恶性者ADCratio显著低于良性者(0.65±0.29 vs 1.03±0.32,p<0.001)。
  • ADC测量观察者间一致性近乎完美(κ=0.836-0.934)。
  • 控制病灶大小后,ADCratio仍是恶性的显著预测因子(p<0.001)。

核心结论

  • ADCratio在T1高信号小肾肿块中可高度重复测量,且恶性者显著低于良性者,控制病灶大小后仍为恶性显著预测因子。

研究设计与样本

  • 单中心回顾性研究,纳入95例患者共58个良性及37个恶性T1高信号小肾肿块(<4 cm);恶性经病理证实,良性由病理证实、随访超声或随访影像显示稳定超过5年的预设层级标准确定;T1高信号定义为信号强度等于或高于相邻肾皮质,由一名资深腹部放射科医师确认;两名腹部放射科医师独立测量病灶ADC并归一化为背景同侧肾ADC得到ADCratio。

关键影像表现/征象

  • T1高信号可能与小肾肿块内出血有关,可能限制DWI信号强度的评估。
  • T1高信号定义为病灶信号强度等于或高于相邻肾皮质。

诊断标准与关键数值

  • ADCratio在恶性组为0.65±0.29,良性组为1.03±0.32,恶性组显著低于良性组(p<0.001)。
  • ADC测量观察者间一致性近乎完美(κ=0.836-0.934)。
  • 恶性病灶显著大于良性病灶(2.66±0.86 cm vs 1.50±0.65 cm,p<0.001);控制病灶大小后ADCratio仍为恶性显著预测因子(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. Small renal masses (< 4 cm) can be difficult to accurately classify as benign or malignant, particularly when they appear T1 hyperintense on MRI. This intrinsic signal, potentially related to intralesional hemorrhage, may limit evaluation of signal intensity on DWI. The purpose of this study was to test whether apparent diffusion coefficient (ADC) measurements may distinguish malignancy. MATERIALS AND METHODS. This single-center retrospective study identified patients with a T1-hyperintense renal mass less than 4 cm on MRI. Malignant lesions were pathologically proven; a benign mass was established by a predefined hierarchy of pathologic proof, follow-up ultrasound, or follow-up imaging showing more than 5 years of stability. T1 hyperintensity, defined as a signal intensity equivalent to or greater than the adjacent renal cortex, was confirmed by a senior abdominal radiologist. Two additional abdominal radiologists independently measured ADC of the lesion, which was normalized to the ADC of the background ipsilateral kidney and represented as ADCratio. RESULTS. The final cohort included 58 benign and 37 malignant renal lesions in 95 patients. Interrater agreement for ADC measurements was almost perfect (κ = 0.836-0.934). ADCratio was significantly lower in malignant compared with benign lesions (0.65 ± 0.29 vs 1.03 ± 0.32; p < 0.001). Malignant lesions were significantly larger than benign lesions (2.66 ± 0.86 cm vs 1.50 ± 0.65 cm; p < 0.001); however, after controlling for lesion size, ADCratio remained a significant predictor of malignancy (p < 0.001). CONCLUSION. ADCratio was highly reproducible for T1-hyperintense small renal masses and was significantly lower in malignant compared with benign renal masses.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ludwig DR, Ballard DH, Shetty AS, et al. Apparent Diffusion Coefficient Distinguishes Malignancy in T1-Hyperintense Small Renal Masses. AJR Am J Roentgenol. 2019. PMID: 31573857. doi:10.2214/AJR.19.21907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。